Abstract:Owing to its intricate pathophysiology, cerebral stroke is a serious medical condition caused by interruption or obstruction of blood supply (blockage of vasculature) to the brain tissues which results in diminished supply of essential nutrients and oxygen (hypoxia) and ultimate necrosis of neuronal tissues. A prompt risks assessment and immediate rational therapeutic plan with proficient neuroprotection play critically important role in the effective management of this neuronal emergency. Various conventional medications are being used for treatment of acute ischemic cerebral stroke but fibrinolytic agents, alone or in combination with other agents are considered the mainstay. These clot-busting agents effectively restore blood supply (reperfusion) to ischemic regions of the brain; however, their clinical significance is hampered due to various factors such as short plasma half-life, limited distribution to brain tissues due to the presence of highly efficient physiological barrier, blood brain barrier (BBB), and lacking of target-specific delivery to the ischemic brain regions. To alleviate these issues, various types of nanomedicines such as polymeric nanoparticles (NPs), liposomes, nanoemulsion, micelles and dendrimers have been designed and evaluated. The implication of these newer therapies (nanomedicines) have revolutionized the therapeutic outcomes by improving the plasma half-life, permeation across BBB, efficient distribution to ischemic cerebral tissues and neuroprotection. Furthermore, the adaptation of some diverse techniques including PEGylation, tethering of targeting ligands on the surfaces of nanomedicines, and pH responsive features have also been pondered. The implication of these emerging adaptations have shown remarkable potential in maximizing the targeting efficiency of drugs to ischemic brain tissues, simultaneous delivery of drugs and imaging agents (for early prognosis as well as monitoring of therapy), and therapeutic outcomes such as long-term neuroprotection.

Microenvironment-responsive nanosystems for ischemic stroke therapy

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Application of stimuli-responsive nanomedicines for the treatment of ischemic stroke

Ischemic Microenvironment‐Responsive Therapeutics for Cardiovascular Diseases

Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Advanced nano drug delivery systems for neuroprotection against ischemic stroke

Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system

Nanomedicine for Ischemic Stroke

Nanoparticles-mediated Emerging Approaches for Effective Treatment of Ischemic Stroke.

Recent advances in the development of nanomedicines for the treatment of ischemic stroke

Advances in nanoparticle-based therapeutics for ischemic stroke: Enhancing drug delivery and efficacy

Advanced Drug Delivery System Against Ischemic Stroke

A Mechanistic Systems Biology Model of Brain Microvascular Endothelial Cell Signaling Reveals Dynamic Pathway-Based Therapeutic Targets for Brain Ischemia

Advanced Nano-Drug Delivery Systems in the Treatment of Ischemic Stroke

Recent advances in nanomedicines for the treatment of ischemic stroke

Advances in nanomedicines: a promising therapeutic strategy for ischemic cerebral stroke treatment

Nanotechnology approaches to drug delivery for the treatment of ischemic stroke

Sulfated Polysaccharide-Based Nanocarrier Drives Microenvironment-Mediated Cerebral Neurovascular Remodeling for Ischemic Stroke Treatment

The Role of Nanomaterials in Revolutionizing Ischemic Stroke Treatment: Current Trends and Future Prospects

Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review